Hospitals prop up med schools, but now it's squeezing their bottom lines; Pfizer to seek Covid booster for younger kids

Cash-strapped med schools have long relied on hospital money, but the transfers are getting attention as executives try to shore up finances. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Hospitals have been financially propping up medical schools, but now it's squeezing their bottom lines By Tara Bannow Molly Ferguson for STAT Cash-strapped med schools have long relied on hospital money, but the transfers are getting attention as executives try to shore up finances. Read More Pfizer to seek Covid booster for healthy 5- to 11-year-olds By Lauran Neergaard — Associated Press Cindy Ord/Getty Images for Pfizer/BioNTech The company says new data shows healthy 5- to 11-year-olds could benefit from another shot of the vaccine. Read More STAT+: 'Completely unsustainable': Small employers brace for giant health insurance price hikes By Bob Herman Adobe People who work in or own small businesses might get hammered with significantly higher health insurance premiums next year. Read More Sponsor content by STAT Color Code Podcast "Color Code" Podcast: STAT's podcast raising the alarm on racial inequities in American health care In this eight-episode podcast, award-winning journalist and host Nicholas St. Fleur weaves together stories and experiences of physicians, patients, historians, and other experts to illuminate the history of racism in the health care system and how it has — and continues to — impact people of color and underserved communities. Add "Color Code" to your STAT podcasts listening list and stream each episode on your preferred platform. Listen now. STAT+: Editas Medicine names new CEO — its fourth — as delays, poor data hamper its gene-editing treatments By Adam Feuerstein Ruby Wallau for STAT Gilmore O’Neill, the chief medical officer at Sarepta Therapeutics, takes over as Editas’ CEO on June 1, the company said. Read More Opinion: Devastating separations continue for families seeking asylum, with dire health consequences By Annie Leone John Moore/Getty Images U.S. policies to split up families compound the trauma of asylum seekers, raising the risk of harmful outcomes for mothers and babies. Read More STAT+: Omicron's speedy retreat helped bolster UnitedHealth Group's bottom line By Bob Herman Jim Mone/AP The Omicron surge didn’t lead to an explosion of medical claims at UnitedHealth Group, which contributed to higher-than-expect profits. Read More Listen: Leana Wen on the pandemic's new normal and whether Twitter is real life By Damian Garde and Meg Tirrell and Adam Feuerstein Doctor and professor Leana Wen joins us to talk about the many complexities of living with Covid and the tricky task of defining "normal." Read More Thursday, April 14, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser